ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014

NCI To Establish New Offices for Special Populations, Survivorship, Klausner Tells House appropirations Subcommittee

May 3, 1996

NCI To Use Technology Transfer Agreement To Privatize Journal In A Five-Year Deal

December 1, 1995

1981 Budget By Funding Mechanism

June 1, 1979

Beta Carotene Doesn’t Help, May Hurt, Two Trials Find

January 26, 1996

Growing Number Of New Research Ideas Create NCI Dilemma; How to Fund Them With A Flat Budget

October 1, 1982